THE IMPACT OF THE METHOD OF PREVENTION OF INTRAUTERINE INFECTION ON THE STATE OF NONSPECIFIC IMMUNITY IN PREGNANT WOMEN WITH RELAPSING HERPETIC INFECTION AND THEIR CHILDREN

Purpose of the study: to assess the state of nonspecific immunity in women with relapsing herpetic infection, planning pregnancy, period of gestation, from infants and children in the first six months of life, depending on the method of prophylaxis of relapses of infection and intrauterine infection.

Patients and methods: under observation were 342 pregnant women with relapsing herpetic infection and their children. Testing for the presence of HSV infection was performed using methods of PCR and ELISA. Women and their children were studied: interferon status, indicators of phenotyping of lymphocytes, the levels of tumor necrosis factor, growth factor of the placenta, placental alkaline phosphatase, placental alpha-1 microglobulin, interleukin 10, immunoglobulin classes A, M, G; for the assessment of fetoplacental complex was used ultrasonic methods. The health status of infants and children in the first six months of life was estimated taking into account the diagnosis of intrauterine infection with herpes simplex virus and realization of somatic pathology.

Results of the study: validated method of prevention of intrauterine infection of the fetus with the use of the drug Alloferon on degustatsionnom stage and human recombinant interferon Alfa-2b in the antenatal period. A proven Association between the efficiency of consequent preventive therapy and frequency of complications of gestation, intrauterine infection with herpes simplex virus, the state of nonspecific immunity in pregnant women, newborns and children in the first six months of life.

Conclusion: for recurrent herpes infection during pregnancy, an imbalance in the system of nonspecific immunity, development planetarnoi failure lead to tensions antiinfectious immunity in the neonatal period in children with intrauterine infection, and in uninfected children. Newborn children with the implementation of the herpes infection observed inhibition of nonspecific immunity. Milestone method of prevention of intrauterine infection of the fetus with the use of drugs Alloferon and human recombinant interferon Alfa-2b meets the modern requirements of perinatal pharmacology, accessible and safe.

1. Mardanly S.G. Zadachi i perspektivy sovershenstvovanija klinicheskoj laborotornoj diagnostiki infekcij gruppy TORCH / S.G. Mardanly // Vestnik sluzhby krovi Rossii. – 2013. – №2. – S. 54-60

2. Ovchinnikova M.A. Vlijanie recidivirujushhego techenija gerpeticheskoj infekcii u beremennyh na fetoplacentarnyj kompleks i techenie rannego neonatal’nogo perioda u detej / M.A. Ovchinnikova // Aspirantskij vestnik Povolzh’ja. – 2014. – № 1 (2). – S. 123-7.

3. Jarilin A.A. Immunologija / A.A. Jarilin. – M.: GJeOTARMedia, 2010. – 749s.

4. Lang Ph.A, Cervantes-Barragan L., Verschoor A. at al. Hematopoietic cell–derived interferon controls viral replication and virus-induced disease // Blood. – 2009. – Vol. 113, №5. – P. 1045-1052. DOI: https://doi.org/10.1182/ blood-2007-10-117861

5. Koval’chuk L.V. Klinicheskaja immunologija i allergologija s osnovami obshhej immunologii // L.V. Koval’chuk, L.V. Gankovskaja, R.Ja. Meshkova. – M.: GJeOTAR-Media, 2012. – 639s.

6. Vikulov G.H. Immunologicheskie aspekty gerpes-virusnyh infekcij /G.H. Vikulov // Klinicheskaja dermatologija i venerologija. – 2015. – № 14 (5). – S. 104-116.

7. Bogdanova I.M. Immunnyj kontrol’ reprodukcii. Rol’ reguljatornyh T-kletok v indukcii immunologicheskoj tolerantnosti pri beremennosti / I.M. Bogdanova, M.N. Boltovskaja // Klinicheskaja i jeksperimental’naja morfologija. – 2015. – № 3 (15). – S. 59-67.

8. Isakov V.A. Patogenez i lechenie social’no znachimyh virusnyh urogenital’nyh infekcij (gerpesa i papillomavirusnoj infekcii) /V.A. Isakov, D.V. Isakov // Klinicheskaja farmakologija i terapija. – 2014. – T. 23, № 1. – S. 68-74.

9. Gazazjan M.G. Faktory riska realizacii vnutriutrobnoj infekcii u novorozhdennogo / M.G. Gazazjan, E.D. Strebkova // Zhurnal nauchnyh statej Zdorov’e i obrazovanie v XXI veke. – 2016. – № 18 (12). – S. 83-86.

10. Simon K., Hollander G., McMichael A. Evolution of the immune system in humans from infancy to old age // Proceedings of the royal society Biological sciences. – 2015. – Vol. 282. – P. 1-9. DOI: 10.1098/rspb.2014.3085

11. Mollaeva N.O. Izuchenie citokinovogo statusa u novorozhdennyh i detej grudnogo vozrasta s vnutriutrobnymi infekcijami / N.O. Mollaeva, G.M. Nasrullaeva, N.D. Guliev // Medicinskie novosti. – 2011. – № 2. – S. 98–100.

12. Klimova R.R. Vlijanie virusnyh infekcij na citokinovyj profil’ u beremennyh zhenshhin s otjagoshhennym akusherskim anamnezom i immunokorregirujushhaja terapija interferonom al’fa 2b cheloveka / R.R. Klimova [i dr.] // Voprosy virusologii. – 2013. – № 58 (1). – S. 18-23.

13. Mlynarczyk-Bonikowska B., Malejczyk M., Majewski S. at al. Antiviral medication in sexually transmitted diseases. Part I: HSV, HPV // Mini-Reviews in Medicinal Chemistry. – 2013. – Vol. 13, № 13. – P. 1837-1845.

14. Repin I.V. Opyt primenenija preparatov interferona v lechenii hronicheskih urogenital’nyh infekcij u zhenshhin / I.V. Repin, S.A. Hlynova, E.V. Chernjaeva // Doktor Ru. – 2014. – № 1 (5). – S. 33-41.

15. Duda A.K. Primenenie protivovirusnogo preparata novogo pokolenija Allokin-al’fa v terapii social’no znachimyh virusnyh infekcij / A.K. Duda, L.P. Kocjubajlo, N.V. Okruzhnov // Aktual’naja infektologija. – 2014. – № 4 (5). – S. 32-41.

16. Sosnova E.A. Pregravidarnaja podgotovka pacientok s virusnymi infekcijami / E.A. Sosnova // Voprosy ginekologii, akusherstva i perinatologii. – 2011. – T. 10, № 5. – S. 72-78.

17. Nesterova I.V. Modificirovannaja programma kombinirovannoj interferono- i immunoterapii pri associirovannyh respiratornyh i gerpeticheskih virusnyh infekcijah u immunokomprometirovannyh detej / I.V. Nesterova [i dr.] // Jeffektivnaja farmakoterapija. – 2013. – №27. – S. 26-32.

18. Klinicheskie rekomendacii (protokol lechenija) okazanija medicinskoj pomoshhi vzroslym bol’nym prostym gerpesom // Utverzhdeno na zasedanii Profil’noj komissii Minzdrava RF po special’nosti «infekcionnye bolezni» 04 nojabrja 2016 g.

19. Tezikov Ju.V. Informativnost’ prediktorov bol’shih akusherskih sindromov u beremennyh s jembrioplacentarnoj disfunkciej / Ju.V. Tezikov [i dr.] // Aspirantskij vestnik Povolzh’ja. – 2015. – № 5 (6). – S. 48-55.

20. Lipatov I.S. Universal’nyj podhod k profilaktike sindroma patologicheskoj beremennosti / I.S. Lipatov [i dr.] // Nauka i innovacii v medicine. – 2017. – №1. – S. 13-23.

21. Kotel’nikov G.P. Dokazatel’naja medicina. Nauchnoobosnovannaja medicinskaja praktika: monografija. – izd. 2-e pererab i dop. / G.P. Kotel’nikov, A.S. Shpigel’ – M.: GJeOTAR-Media, 2012. – 242 s.